retatrutide clinical trial weight loss results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a How Does Retatrutide Work? Doctor

CrossRef Real-world assessment of effectiveness and safety profile of remogliflozin etabonate in management of type 2 diabetes mellitus Bipin Sethi, Subhankar Chowdhury, Supratik Bhattacharya, Sagar Katare, Sachin Suryawanshi, Hanmant Barkate International Journal of Diabetes in Developing Countries.2023

The confusion likely stems from a different class of diabetes medication, one that genuinely does increase UTI risk through a completely different mechanism

While the hazard ratio (HR) was 1.60, the absolute numbers were small (3% vs 0.5%)

Therefore, to safely harness the attractive catabolic and thermogenic effects of glucagon for treating metabolic disease, a counter-balancing therapy that selectively opposes the risk for glucagon-induced hyperglycaemia is required

References Bailey RA, Wang Y, Zhu V, Rupnow MFT

The findings from this study suggest that the silencing of the DPP-IV gene exerts a significant impact on the molecular and cellular processes associated with PTC progression, primarily through modulation of the MAPK pathway and the expression of key regulatory factors